July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two ...
A diabetes drug was linked to a surprising effect on the risk of dementia.
Health chiefs have been accused of exaggerating the cost of administering breakthrough Alzheimer’s drugs, resulting in their rollout being blocked.
Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.
Scientists found a drug that can clear out toxic proteins in the brain, according to a study published in the journal ACS ...
6don MSN
Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug strategy
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new ...
A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...
Dementia care has to do more than slow biological decline. It also has to ask what helps a person feel recognised, connected, ...
Newsable Asianet News on MSN
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership
Merck cited business reasons for the discontinuation of the investigational drug.
New research suggests your brain may be sending Alzheimer's warning signals years before you ever forget a thing.
MedPage Today on MSN
Diabetes Drug Class Tied to Lower Dementia Risk in People With Psych Disorders
SGLT2 inhibitor use also correlated with lower rates of psychiatric ED visits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results